gabexate has been researched along with Injuries in 4 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Injuries: Used with anatomic headings, animals, and sports for wounds and injuries. Excludes cell damage, for which pathology is used.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The systemic effects of epidermal growth factor (EGF) ointment containing nafamostat (NM), gabexate, or gelatin was studied in rats with burns or open wounds." | 7.68 | Systemic effects of epidermal growth factor (EGF) ointment containing protease inhibitor or gelatin in rats with burns or open wounds. ( Fuwa, T; Iwakawa, S; Kiyohara, Y; Komada, F; Okumura, K, 1993) |
| "The systemic effects of epidermal growth factor (EGF) ointment containing nafamostat (NM), gabexate, or gelatin was studied in rats with burns or open wounds." | 3.68 | Systemic effects of epidermal growth factor (EGF) ointment containing protease inhibitor or gelatin in rats with burns or open wounds. ( Fuwa, T; Iwakawa, S; Kiyohara, Y; Komada, F; Okumura, K, 1993) |
| "Whereas in DIC associated with trauma, since balance between coagulation and fibrinolysis collapses drastically in a short period, both anticoagulantion therapy and antifibrinolytic therapy can be utilized depending on clinical conditions." | 2.53 | [Anti DIC therapy]. ( Sakamoto, Y; Yahata, M, 2016) |
| "Nafamostat was more efficient than gabexate or gelatin on wound healing." | 1.28 | Improvement in wound healing by epidermal growth factor (EGF) ointment. I. Effect of nafamostat, gabexate, or gelatin on stabilization and efficacy of EGF. ( Fuwa, T; Hirai, M; Iwakawa, S; Kiyohara, Y; Komada, F; Okumura, K, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yahata, M | 1 |
| Sakamoto, Y | 1 |
| Aki, T | 1 |
| Egashira, N | 1 |
| Yamauchi, Y | 1 |
| Hama, M | 1 |
| Yano, T | 1 |
| Itoh, Y | 1 |
| Yamada, T | 1 |
| Oishi, R | 1 |
| Kiyohara, Y | 2 |
| Komada, F | 2 |
| Iwakawa, S | 2 |
| Fuwa, T | 2 |
| Okumura, K | 2 |
| Hirai, M | 1 |
1 review available for gabexate and Injuries
| Article | Year |
|---|---|
[Anti DIC therapy].
Topics: Anticoagulants; Antifibrinolytic Agents; Antithrombins; Benzamidines; Disseminated Intravascular Coa | 2016 |
3 other studies available for gabexate and Injuries
| Article | Year |
|---|---|
Protective effects of amino acids against gabexate mesilate-induced cell injury in porcine aorta endothelial cells.
Topics: Amino Acids; Animals; Aorta; Endothelium, Vascular; Gabexate; Glycine; Necrosis; Propidium; Receptor | 2008 |
Systemic effects of epidermal growth factor (EGF) ointment containing protease inhibitor or gelatin in rats with burns or open wounds.
Topics: Animals; Aspartate Aminotransferases; Benzamidines; Body Weight; Burns; Drug Interactions; Drug Syne | 1993 |
Improvement in wound healing by epidermal growth factor (EGF) ointment. I. Effect of nafamostat, gabexate, or gelatin on stabilization and efficacy of EGF.
Topics: Animals; Benzamidines; Biotransformation; Dose-Response Relationship, Drug; Drug Combinations; Drug | 1990 |